Genologics Closes Second Round of VC Cash to Help Market Software | GenomeWeb
NEW YORK (GenomeWeb News) — Genologics Life Sciences yesterday said it has closed a second round of private equity financing.
 
Genologics said it plans to use the undisclosed funding primarily to market its bioinformatics software to pharmaceutical labs specializing in proteomics, genomics, and systems biology research.
 
The financing was led by OVP Venture Partners and included investments from Growth Works and Yaletown Venture Partners.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.